TransMedics Group, Inc. (TMDX) › Capital ExpendituresTransMedics Group, Inc. (TMDX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $418.0K2019: $165.0K2020: $455.0K2021: $3.52M2022: $11.91M2023: $151.85M2024: $129.74M2025: $59.25M$59.25M2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$59.25M-54.3%2024$129.74M-14.6%2023$151.85M+1175.3%2022$11.91M+238.4%2021$3.52M+673.4%2020$455.0K+175.8%2019$165.0K-60.5%2018$418.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share